GW Pharmaceuticals Will Be Acquired for $7.2 Billion

Ganjapreneur
By Graham AbbottFeb 3, 2021, 12:57 pm284 pts
The United Kingdom-based GW Pharmaceuticals Plc will be acquired by Jazz Pharmaceuticals Plc in a $7.2 billion cash-and-stock deal, MarketWatch reports. The deal, announced this week, is expected to close sometime in the second quarter of 2021 in hopes of boosting first-year profits after the close and in order…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Cybersecurity Researcher Uncovers Over 957,000 Medical Cannabis Patient Records on Unsecured Database 77

Tilray Is a Dangerous Stock 76

Canadian cannabis market matures: legal sales up, price gap narrows in first five years 66

Supreme Court cases may force Trump administration to articulate marijuana policy 50

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.